{
    "clinical_study": {
        "@rank": "69080", 
        "brief_summary": {
            "textblock": "Multi-center, prospective randomized dosing and safety research study.  A maximum of 150 men\n      will be enrolled in the study. Qualifying patients will receive one of three possible doses\n      of the study drug. Symptoms will be evaluated before treatment, and then 1-week, 1-month,\n      3-months, and 6-months following treatment."
        }, 
        "brief_title": "Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate)", 
        "completion_date": "March 2004", 
        "condition": [
            "Prostate Disease", 
            "BPH", 
            "Benign Prostatic Hyperplasia", 
            "Benign Prostatic Hypertrophy"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Prostatic Hyperplasia", 
                "Hyperplasia", 
                "Hypertrophy", 
                "Prostatic Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Eligible patients are 50 to 80-year-old men who have experienced some or all of the\n        following urinary symptoms for at least 6 months:\n\n          -  frequent or urgent need to urinate\n\n          -  difficulty starting their urinary stream\n\n          -  interruption of their urinary stream\n\n          -  feeling of incomplete emptying of bladder after urinating\n\n          -  interruption of sleep due to the urge to urinate\n\n        Patients should have tried oral medication for their condition in the past, and be willing\n        to discontinue any current BPH medications for a period of time before undergoing study\n        treatment.  They should be in good general health and have no previous surgery, or other\n        procedure(s) intended to reduce prostate size."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": "150", 
        "firstreceived_date": "May 15, 2002", 
        "id_info": {
            "nct_id": "NCT00037141", 
            "org_study_id": "AMS002"
        }, 
        "intervention": {
            "intervention_name": "dehydrated alcohol", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Ethanol"
        }, 
        "keyword": [
            "Prostate", 
            "BPH", 
            "Prostatitis"
        ], 
        "lastchanged_date": "October 4, 2007", 
        "official_title": "Evaluation of the Safety and Tolerability of Transurethral Alcohol Injection for the Treatment of BPH (Enlarged Prostate)", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 1/Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00037141"
        }, 
        "source": "American Medical Systems", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "American Medical Systems", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2002", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2004"
    }, 
    "geocoordinates": {}
}